Main Article Content



Background: COVID-19 vaccination is the administration of a vaccine to help the individuals to protect from COVID-19. COVID-19 vaccines have been unfurled in several parts of the world. Although the protective efficacy was frequently discussed and analysed, little is known about post-vaccination experience outside of clinical trial conditions. The aim of the study was symptoms following COVID-19 vaccination in selected area, Puducherry, with the objectives of to assess the immediate response to the first dose of COVID-19 vaccine and to study the spectrum of post-vaccination symptom profile for individual vaccines.

Methodology: Quantitative approach and non-experimental cross-sectional design was used. The study was conducted in selected areas in Puducherry. 30 subjects were recruited by using convenience                           sampling technique.  Demographic variable questionnaire and self-developed binary tools was                               used.

Results: The study results revealed that the Overall, all 30(100%) of respondents reported at least one post-vaccination symptom. 9(30%) had the symptoms of body ache, 7(23.3%) had fever, 6(20%) had local pain at injection site, 5(16.7%) had tiredness and 3(10%). Among male 10(33.3%) had paracetamol intake, 3(10%) had symptoms following vaccine, 4(13.3%) had symptoms within duration of hours and only 1(3.3%) had symptoms after onset in hours. Among female 10(33.3%) had taken paracetamol, 9(30%) had symptoms following vaccine, 7(23.4%) had symptoms within duration of hours and only 4(13.4%) had symptoms after onset in hours.

Conclusion: Body ache and fever was most commonly reported. These symptoms were consistent with an immune response commonly associated with vaccines.  In 90% cases, the symptoms were either milder than expected or meeting the expectation of the vaccine recipient. No serious events were reported. Symptoms were more common among younger individuals.

Vaccine, COVID-19, COVID-19 Symptoms

Article Details

How to Cite
ELAKKIYA, P., & KURUSHEV, J. (2022). A CROSS SECTIONAL ONLINE SURVEY ON SYMPTOMS FOLLOWING COVID-19 VACCINATION. Journal of Medicine and Health Research, 7(1), 28-35. Retrieved from https://ikpresse.com/index.php/JOMAHR/article/view/7672
Original Research Article


World Health Organization. Global health observatory data repository: Causes of death; 2019-2020.

World health organization (WHO), ENCES Modes of transmission of the virus causing COVID-19: implications for IPC precaution recommendation; 2020.

Vaccines and Related Biological Products Advisory Committee Meeting. FDA; 2020.

Mahase E. Covid-19: Pfizer vaccine efficacy was 52% after first dose and 95% after second dose, paper shows.

Voysey M, Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99-111.

Wadman M. Public needs to prep for vaccine side effects; 2020.

Callaway E. Oxford covid vaccine results puzzle scientists. Nature; 2020

Sharma D, Covid-19: post-vaccine symptoms more common in young than elderly, says study; 2021.

Zeneca, one in four people experience mild side effects from Covishield vaccine: Lancet study; 2021.

RK Srivastava, The initial experience of COVID-19 vaccination from a tertiary care centre of India,

PMID: 33794595, DOI: 10.4081/monaldi.2021.1816

Michaud A, Cousens X, Sanchez B, Covid-19 Vaccine Experiences from Around the U.S; 2021.